Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Carbinoxamine maleate 1 mg/mL and pseudoephedrine hydrochloride 15 mg/mL oral solution |
Has concentration strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
2 |
Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL and dexamethasone 1 mg/mL ear suspension |
Has concentration strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine 1 microgram/1 milligram and lidocaine hydrochloride 100 microgram/1 milligram conventional release cutaneous patch (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
1 |
Codeine phosphate 2 mg/mL and phenylephrine hydrochloride 1 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
Has concentration strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
3 |
Diphenhydramine hydrochloride 20 mg/mL and zinc acetate 1 mg/mL cutaneous cream |
Has concentration strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
2 |
Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
2 |
Brompheniramine maleate 400 microgram/mL and guaifenesin 40 mg/mL and hydrocodone bitartrate 1 mg/mL oral solution |
Has concentration strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
2 |
Product containing precisely codeine phosphate 1 milligram/1 milliliter and kaolin 300 milligram/1 milliliter conventional release oral suspension (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
un |
Inferred relationship |
Some |
1 |
TUBERSOL 5 Tuberculin units per test dose 0.1 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) |
Has concentration strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
TUBERSOL 5 Tuberculin units per test dose 0.1 milliliter solution for injection Sanofi Pasteur Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Pneu-C-7 pneumococcal conjugate 7-valent unspecified |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
BEXSERO suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
SYNAGIS 100 milligrams per milliliter powder for solution for injection Boehringer Ingelheim (BI) Pharma KG (real clinical drug) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
SYNAGIS 100 milligrams per milliliter powder for solution for injection Boehringer Ingelheim (BI) Pharma KG (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
EJ IXIARO VAL |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Typh-O Vivotif Pax |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Menactra solution for injection Sanofi Pasteur Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Men-C-CY méningocoque conjugué C + Y non spécifié |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
ProHIBiT 23 micrograms per 0.5 milliliter solution for injection Aventis Pasteur Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Zos ZOSTAVAX MC |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Inf FLUAD Pediatric SEQ |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
MENJUGATE Liquid 10 micrograms suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only live attenuated Influenza virus antigen (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Typh-I TYPHIM Vi SP |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Sma IMVAMUNE BN |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only meningococcal groups A + C + Y + W-135 capsular polysaccharide unconjugated antigens (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
BCG Vaccine 1.5 microgram per 0.1 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Pediatric vaccine product containing only Hepatitis A virus low strength antigen (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
RotaTeq 115000000 units per 2 milliliter oral solution Merck Canada Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Inf AFLURIA TETRA SEQ |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only Rotavirus 1 serotype antigen (medicinal product) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
VariZIG 125 international units powder and diluent for solution for injection Cangene Corporation (real clinical drug) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Vaccine product containing only Rotavirus 1 serotype antigen (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus low dose each non-live antigen in parenteral dose form (medicinal product form) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Cholera + E. coli oral vaccine (medicinal product form) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Pneu-C-13 pneumococcal conjugate 13-valent unspecified |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
CERVARIX 40 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
MENJUGATE Liquid 10 micrograms suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Adult vaccine product containing only Hepatitis A virus regular strength antigen (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
RabAvert 2.5 international units per milliliter powder for solution for injection Novartis Vaccines and Diagnostics Gmbh (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Inf influenza A virus subtype H1N1 unspecified |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
FLUZONE High-Dose 60 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
BAtx BAT EBS |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
BabyBIG [Botulism Immune Globulin Intravenous (Human) (BIG-IV)] 50 milligrams per milliliter powder for solution for infusion California Department of Public Health (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
NIMENRIX powder and diluent for solution for injection Pfizer Canada Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
VarIg VariZIG STR |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus high dose each non-live antigen in parenteral dose form (medicinal product form) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only Neisseria meningitidis serogroup C conjugated antigen (medicinal product) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
TBE FSME-IMMUN Bax |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Act-HIB 10 micrograms per 0.5 milliliter powder and diluent for solution for injection Sanofi Pasteur Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
RECOMBIVAX HB 5 micrograms per 0.5 milliliter suspension for injection Merck Canada Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Adjuvanted vaccine product containing only non-live Influenza A virus subtype H1N1 antigen in parenteral dose form (medicinal product form) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
YF-VAX 109648 plaque forming units per 0.5 milliliter powder and diluent for suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only meningococcal groups A + C capsular polysaccharide unconjugated antigens (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Intanza 9 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only Human papillomavirus 2 serotypes antigens (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Prevnar 16 micrograms per 0.5 milliliter suspension for injection Pfizer Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
ZOSTAVAX II 19400 plaque forming units per 0.65 milliliter powder and diluent for suspension for injection Merck Canada Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
BabyBIG [Botulism Immune Globulin Intravenous (Human) (BIG-IV)] 50 milligrams per milliliter powder for solution for infusion California Department of Public Health (real clinical drug) |
Has presentation strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Vaccine product containing only meningococcal A capsular polysaccharide unconjugated antigen (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only Human papillomavirus 9 serotypes antigens (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
BAT [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)] solution for injection Cangene Corporation (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Men-B Trumenba Pfiz |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection Pfizer Canada ULC (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Hiberix 10 micrograms per 0.5 milliliter powder and diluent for solution for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
VarIg VariZIG STR |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
GARDASIL 120 micrograms per 0.5 milliliter suspension for injection Merck Canada Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Engerix B 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
HyperHEP B S/D 220 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Inf AGRIFLU SEQ |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only Influenza A virus 1 strain antigen (medicinal product) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only Neisseria meningitidis serogroup C antigen (medicinal product) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
CMVIg Cytogam STR |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only Influenza A virus 1 strain antigen (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
IMOGAM 150 international units per milliliter solution for injection Sanofi Pasteur SA (real clinical drug) |
Has concentration strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Meningitec 10 micrograms suspension for injection Berna Biotech, AG (real clinical drug) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
MENJUGATE 10 micrograms powder and diluent for suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only pneumococcal 23 serotypes polysaccharide unconjugated antigens (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
FLUMIST QUADRIVALENT 0.2 milliliter intranasal spray AstraZeneca Canada (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Menveo powder and solution for injection Novartis Vaccines and Diagnostics Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
HyperHEP B S/D 220 international units per milliliter solution for injection Grifols Canada Limited (real clinical drug) |
Has concentration strength denominator value |
False |
un |
Inferred relationship |
Some |
1 |
Men-C-ACYW-135 NIMENRIX GSK |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
NeisVac-C 10 micrograms per 0.5 milliliter suspension for injection Pfizer Canada ULC (real clinical drug) |
Count of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaccine product containing only meningococcal groups A + C + Y + W-135 conjugate antigens (medicinal product) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
IMOGAM 150 international units per milliliter solution for injection Sanofi Pasteur SA (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
BCG vaccin IDM |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Pneumovax 23 solution for injection Merck Canada Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Inf FLUAD SEQ |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|
Diphtheria antitoxin (equine) 170 milligrams per milliliter solution for injection Institute of Immunology Inc. (real clinical drug) |
Count of base of active ingredient |
False |
un |
Inferred relationship |
Some |
|